TY - JOUR
T1 - Dual contrast agents for fluorescence and photoacoustic imaging
T2 - Evaluation in a murine model of prostate cancer
AU - Lesniak, Wojciech G.
AU - Wu, Yixuan
AU - Kang, Jeeun
AU - Boinapally, Srikanth
AU - Ray Banerjee, Sangeeta
AU - Lisok, Ala
AU - Jablonska, Anna
AU - Boctor, Emad M.
AU - Pomper, Martin G.
N1 - Publisher Copyright:
© 2021 The Royal Society of Chemistry.
PY - 2021/5/28
Y1 - 2021/5/28
N2 - Prostate-specific membrane antigen (PSMA) is a promising diagnostic and therapeutic target for prostate cancer (PC). Poly(amidoamine) [PAMAM] dendrimers serve as versatile scaffolds for imaging agents and drug delivery that can be tailored to different sizes and compositions depending upon the application. We have developed PSMA-targeted PAMAM dendrimers for real-time detection of PC using fluorescence (FL) and photoacoustic (PA) imaging. A generation-4, ethylenediamine core, amine-terminated dendrimer was consecutively conjugated with on average 10 lysine-glutamate-urea PSMA targeting moieties and a different number of sulfo-cyanine7.5 (Cy7.5) near-infrared dyes (2, 4, 6 and 8 denoted as conjugates II, III, IV and V, respectively). The remaining terminal primary amines were capped with butane-1,2-diol functionalities. We also prepared a conjugate composed of Cy7.5-lysine-suberic acid-lysine glutamate-urea (I) and control dendrimer conjugate (VI). Among all conjugates, IV showed superior in vivo target specificity in male NOD-SCID mice bearing isogenic PSMA+ PC3 PIP and PSMA- PC3 flu xenografts and suitable physicochemical properties for FL and PA imaging. Such agents may prove useful in PC cancer detection and subsequent surgical guidance during excision of PSMA-expressing lesions.
AB - Prostate-specific membrane antigen (PSMA) is a promising diagnostic and therapeutic target for prostate cancer (PC). Poly(amidoamine) [PAMAM] dendrimers serve as versatile scaffolds for imaging agents and drug delivery that can be tailored to different sizes and compositions depending upon the application. We have developed PSMA-targeted PAMAM dendrimers for real-time detection of PC using fluorescence (FL) and photoacoustic (PA) imaging. A generation-4, ethylenediamine core, amine-terminated dendrimer was consecutively conjugated with on average 10 lysine-glutamate-urea PSMA targeting moieties and a different number of sulfo-cyanine7.5 (Cy7.5) near-infrared dyes (2, 4, 6 and 8 denoted as conjugates II, III, IV and V, respectively). The remaining terminal primary amines were capped with butane-1,2-diol functionalities. We also prepared a conjugate composed of Cy7.5-lysine-suberic acid-lysine glutamate-urea (I) and control dendrimer conjugate (VI). Among all conjugates, IV showed superior in vivo target specificity in male NOD-SCID mice bearing isogenic PSMA+ PC3 PIP and PSMA- PC3 flu xenografts and suitable physicochemical properties for FL and PA imaging. Such agents may prove useful in PC cancer detection and subsequent surgical guidance during excision of PSMA-expressing lesions.
UR - http://www.scopus.com/inward/record.url?scp=85106910845&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106910845&partnerID=8YFLogxK
U2 - 10.1039/d1nr00669j
DO - 10.1039/d1nr00669j
M3 - Article
C2 - 33978042
AN - SCOPUS:85106910845
SN - 2040-3364
VL - 13
SP - 9217
EP - 9228
JO - Nanoscale
JF - Nanoscale
IS - 20
ER -